Loren David Walensky
Gründer bei Lytica Therapeutics, Inc.
Aktive Positionen von Loren David Walensky
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Lytica Therapeutics, Inc.
 Lytica Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Lytica Therapeutics, Inc. is an American private company located in Cambridge, MA. The firm operates as a biotech company developing novel peptide conjugates for next-generation ADCs. It was founded by James Joel LaTorre and Loren David Walensky. James Joel LaTorre is the current CEO of the firm. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| Gründer | - | - |
Karriereverlauf von Loren David Walensky
Ehemalige bekannte Positionen von Loren David Walensky
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Bakx Therapeutics, Inc.
 Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bakx Therapeutics is a company based in DE that focuses on developing more effective and precise therapeutics that utilize the mitochondrial apoptosis pathway. The American company's proprietary codynx™ drug discovery platform integrates computational and experimental capabilities to collaborate with researchers in validated biological pathways. Bakx's leading asset, partnered with Ipsen, is focused on activating the bax protein to treat cancer and age-related diseases. Bakx Therapeutics, Inc. was co-founded by world-leading researchers in apoptosis and computationally aided drug discovery. Sree Kant has been the CEO of the company since 2020. | Gründer | - | - |
| AILERON THERAPEUTICS, INC. | Gründer | 06.08.2001 | - |
| Corporate Officer/Principal | 06.08.2001 | - |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Founder | 3 |
| Corporate Officer/Principal | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AILERON THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Lytica Therapeutics, Inc.
Lytica Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Lytica Therapeutics, Inc. is an American private company located in Cambridge, MA. The firm operates as a biotech company developing novel peptide conjugates for next-generation ADCs. It was founded by James Joel LaTorre and Loren David Walensky. James Joel LaTorre is the current CEO of the firm. | Commercial Services |
Bakx Therapeutics, Inc.
Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bakx Therapeutics is a company based in DE that focuses on developing more effective and precise therapeutics that utilize the mitochondrial apoptosis pathway. The American company's proprietary codynx™ drug discovery platform integrates computational and experimental capabilities to collaborate with researchers in validated biological pathways. Bakx's leading asset, partnered with Ipsen, is focused on activating the bax protein to treat cancer and age-related diseases. Bakx Therapeutics, Inc. was co-founded by world-leading researchers in apoptosis and computationally aided drug discovery. Sree Kant has been the CEO of the company since 2020. | Health Technology |
- Börse
- Insiders
- Loren David Walensky
- Erfahrung